Publications

Information on shingles vaccinations for people aged 65 years or older.

Information on shingles vaccinations for people aged 65 years or older.

Information on shingles vaccinations for people aged 65 years or older.

Eighteen month schedule point.

This poster encourages pregnant women to quit smoking.

This document provides evidence-based guidance for clinicians in community and hospital settings, as well as providing a reference source on DSCATT topics. This Guidance Note covers overseas-acquired Lyme disease.

Microbial genomics is revolutionising the diagnosis, surveillance and control of communicable disease in Australia. This national framework identifies policy issues and challenges related to integrating microbial genomics into the Australian public health system.

This report presents the results of post-market validation of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit.

This document is the technical supplement to the Australian Respiratory Surveillance Report (ARSR) series. It describes the technical background and considerations to help interpret the ARSR surveillance data reported nationally for COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

A set of fact sheets to assist residential aged care providers in making decisions about the prevention and control of influenza. They form part of the Influ-Info – Influenza Kit for Residential Aged Care.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This guideline from the Communicable Diseases Network Australia (CDNA) provides information to employers and managers of bird and wildlife workers, including contractors or volunteers. The purpose of the guidelines is to protect these workers from all types of avian influenza (‘bird flu’).

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This poster provides information for Aboriginal and Torres Strait Islander people about the meningococcal B vaccine for infants, and can be used in health care and community settings.

This document for remote communities and organisations highlights the need for the early evacuation of COVID-19 cases, situations in which an evacuation should occur, how these may be coordinated and key considerations for transport.

An information sheet for families and residents on restricted visits to residential aged care facilities to prevent the spread of coronavirus (COVID-19).

This report present results of post-market validation of a further three serological assays
for the detection of SARS-CoV-2 antibodies.